← All trials
NCT01219686
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2010
- Primary completion
- Apr 1, 2013
- Completion date
- Jun 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 18
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- University of GenevaLead sponsor
- University of GenevaOverall official - principal investigator
- University of GenevaSponsor investigator
- LundbeckCollaborator
- University of BernCollaborator
- University of GenevaCollaborator
- University of LausanneCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.